Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07295730 · ClinicalTrials.gov registry record · NA
3D Modalities for Medical Student Education of Congenital Heart Disease
A NA study of Tetralogy of Fallot (TOF) and Hypoplastic Left Heart Syndrome (HLHS), sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT07295730: Completed NA study of Tetralogy of Fallot (TOF) and Hypoplastic Left Heart Syndrome (HLHS), sponsored by Case Western Reserve University.
NCT07295730 is a NA study of Tetralogy of Fallot (TOF) and Hypoplastic Left Heart Syndrome (HLHS) that has completed, run by Case Western Reserve University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07295730, a NA study of Tetralogy of Fallot (TOF) and Hypoplastic Left Heart Syndrome (HLHS), has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are: 1. Does using 3D-printed heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods? 2. Does using augmented reality heart models improve learners' understanding of congenital heart disease when compared to traditional slide-based teaching methods? 3. How can these modalities best be integrated into standard medical school curricula? Participants will: 1. Take a pre-test consisting of questions regarding anatomy and physiology of the normal heart as well as two congenital heart diseases. 2. Be randomized into 3 groups that receive a teaching session using either slide-based lecture, 3D-printed models, or augmented reality. 3. Take a post-test of the same questions from the pre-test. 4. Take a delayed post-test of the same questions with additional subjective questions about their experience with their assigned modality.
Primary Outcome
Participants completed a 16-item, multiple choice questionnaire about the anatomy and physiology of the normal heart and two complex congenital heart defects. The questionnaire is broken down into 4 questions on basic cardiology and 6 questions each pertaining specifically to tetralogy of Fallot and hypoplastic left heart syndrome. The questionnaire is delivered pre-intervention, immediately post-intervention, and again at 3-weeks post intervention. Correct answers are scored as true (1) and inc
Conditions Studied
Interventions
- OTHER 3D-printed heart models and augmented reality
Study Locations (1)
Ohio
- Case Western Reserve University School of Medicine - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2025-11-20 |
| Est. Completion | 2025-12-09 |
| Phase | NA |
What the finished NCT07295730 record still lists
NCT07295730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Tetralogy of Fallot (TOF) appearing as the primary indexed condition, and to 1 intervention - of which 3D-printed heart models and augmented reality is the first listed.
NCT07295730 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07295730 about?
NCT07295730 is a clinical study titled "3D Modalities for Medical Student Education of Congenital Heart Disease". The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are: 1. Does using 3D-printed heart models improve learners' understanding of congenit...
What is the current status of trial NCT07295730?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2025-11-20. Estimated completion is 2025-12-09.
What conditions does trial NCT07295730 study?
This clinical trial studies the following conditions: Tetralogy of Fallot (TOF), Hypoplastic Left Heart Syndrome (HLHS).
What interventions are being tested in trial NCT07295730?
The interventions under investigation include: 3D-printed heart models and augmented reality (OTHER).
Who is sponsoring clinical trial NCT07295730?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07295730 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetralogy of Fallot (TOF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07295730's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI